These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32213442)

  • 21. Utility assessment for different clinical phases of breast cancer in Taiwan.
    Chie WC; Huang CS; Chen JH; Chang KJ
    J Formos Med Assoc; 2000 Sep; 99(9):677-83. PubMed ID: 11000729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
    Paracha N; Abdulla A; MacGilchrist KS
    Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What utility scores do mental health service users, healthcare professionals and members of the general public attribute to different health states? A co-produced mixed methods online survey.
    Flood C; Barlow S; Simpson A; Burls A; Price A; Cartwright M; Brini S;
    PLoS One; 2018; 13(10):e0205223. PubMed ID: 30352071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.
    Augestad LA; Rand-Hendriksen K; Stavem K; Kristiansen IS
    Qual Life Res; 2013 May; 22(4):705-14. PubMed ID: 22678351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of different scenarios for intermittent bladder catheterization on health state utilities: results from an internet-based time trade-off survey.
    Averbeck MA; Krassioukov A; Thiruchelvam N; Madersbacher H; Bøgelund M; Igawa Y
    J Med Econ; 2018 Oct; 21(10):945-952. PubMed ID: 29882712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation.
    Xie S; Wu J; Xie F
    Value Health; 2023 Sep; 26(9):1405-1412. PubMed ID: 37285916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health utilities and willingness to pay in adult patients with coeliac disease in Hungary.
    Angyal MM; Lakatos PL; Jenei B; Brodszky V; Rencz F
    Qual Life Res; 2023 Sep; 32(9):2503-2516. PubMed ID: 37067657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions.
    Matza LS; Boye KS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Health Qual Life Outcomes; 2014 Apr; 12():48. PubMed ID: 24716709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deriving a patient-based utility index from a cancer-specific quality of life questionnaire.
    Grimison PS; Simes RJ; Hudson HM; Stockler MR
    Value Health; 2009; 12(5):800-7. PubMed ID: 19508665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia.
    Tolley K; Goad C; Yi Y; Maroudas P; Haiderali A; Thompson G
    Eur J Health Econ; 2013 Oct; 14(5):749-59. PubMed ID: 22941034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.
    Badia X; Monserrat S; Roset M; Herdman M
    Qual Life Res; 1999 Jun; 8(4):303-10. PubMed ID: 10472162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preference for Alternate-Day Versus Conventional In-Center Dialysis: A Health Utility Elicitation.
    Solimano RJ; Lineen J; Naimark DMJ
    Can J Kidney Health Dis; 2020; 7():2054358120914426. PubMed ID: 32426146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement and comparison of health utility assessments in chronic rhinosinusitis.
    Ference EH; Stubbs V; Lidder AK; Chandra RK; Conley D; Avila PC; Hirsch AG; Min JY; Smith SS; Kern RC; Tan BK
    Int Forum Allergy Rhinol; 2015 Oct; 5(10):929-36. PubMed ID: 26077390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.
    Claassen DO; Ayyagari R; Goldschmidt D; Zhou M; Leo S; Ribalov R
    Adv Ther; 2022 Apr; 39(4):1784-1793. PubMed ID: 35195860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of patients' preferences for chemotherapy: the impact of experience.
    Jansen SJ; Kievit J; Nooij MA; Stiggelbout AM
    Med Decis Making; 2001; 21(4):295-306. PubMed ID: 11475386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.